Beyond Air (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company specializing in nitric oxide (NO) treatments, announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, in New York.
Chairman and CEO Steve Lisi will represent the company, with an on-demand presentation webcast available starting September 5, 2025, at 7:00 a.m. ET. Management will also be available for one-on-one investor meetings during the conference.
An on-demand webcast of the Company’s presentation will be available beginning at 7:00 a.m. ET on Friday, September 5, 2025, on the H.C. Wainwright Conference platform.
In addition, members of management will be available for meetings with investors at the conference. If you are interested in requesting a one-on-one meeting at the conference, please contact your respective representative at H.C. Wainwright to schedule accordingly.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.